9 months ago
ITGR
AnalystsRobert WassermanRobert Wasserman's Stock Forecasts
AnalystsRobert Wasserman
Analyst Ranking
Top 28%
#1400 out of 4937 analysts
Average Return
+1.4%
Win Rate
46%50 out of 109
Risk vs Reward
Poor
Good
Robert Wasserman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunoprecise Antibodies LtdIPA | +311.11% | $0.36 | $1.48 | 2025-04-01 - 2025-07-11 | Buy |
Molekule Group IncMKULQ | +174.00% | $5.00 | $13.70 | 2022-02-01 - 2022-06-14 | Buy |
Ligand Pharmaceuticals IncLGND | +119.54% | $92.48 | $203.03 | 2020-02-06 - 2021-02-05 | Strong Buy |
Nephros IncNEPH | +119.51% | $1.64 | $3.60 | 2024-11-12 - 2025-07-11 | Buy |
Immunoprecise Antibodies LtdIPA | +117.65% | $0.68 | $1.48 | 2024-08-14 - 2025-07-11 | Buy |
Robert Wasserman Analyst Color
Get additional color on Robert Wasserman's coverage of popular stocks
a year ago
LGND
Robert Wasserman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bio Techne CorpTECH | 7 | Strong Buy | $75.00 | +38.53% | Reiterates | a month ago |
Kamada LtdKMDA | 2 | Strong Buy | $15.00 | +93.55% | Reiterates | 2 months ago |
Omniab IncOABI | 9 | Strong Buy | $6.00 | +195.57% | Reiterates | 2 months ago |
Integer Holdings CorpITGR | 11 | Strong Buy | $140.00 | +16.71% | Maintains | 3 months ago |
Xoma Royalty CorpXOMA | 1 | Strong Buy | $35.00 | +28.96% | Initiates Coverage On | 3 months ago |
Immunoprecise Antibodies LtdIPA | 6 | Buy | $3.00 | +102.70% | Reiterates | 3 months ago |
Halozyme Therapeutics IncHALO | 9 | Strong Buy | $75.00 | +31.23% | Reiterates | 5 months ago |
Ligand Pharmaceuticals IncLGND | 10 | Strong Buy | $135.00 | +10.93% | Reiterates | 7 months ago |
Biolife Solutions IncBLFS | 4 | Strong Buy | $30.00 | +36.67% | Reiterates | 7 months ago |
Anebulo Pharmaceuticals IncANEB | 6 | Buy | $8.00 | +381.93% | Reiterates | 8 months ago |
Nephros IncNEPH | 3 | Buy | $5.00 | +38.89% | Reiterates | 8 months ago |
Emergent Biosolutions IncEBS | 16 | Strong Buy | $12.00 | +63.04% | Maintains | 8 months ago |
Intensity Therapeutics IncINTS | 6 | Buy | $12.00 | N/A | Reiterates | a year ago |
Proto Labs IncPRLB | 6 | Strong Buy | $45.00 | N/A | Reiterates | a year ago |
Codexis IncCDXS | 4 | Strong Buy | $9.00 | N/A | Reiterates | a year ago |
Alterity Therapeutics LtdATHE | 1 | Buy | $4.00 | N/A | Reiterates | a year ago |
Processa Pharmaceuticals IncPCSA | 1 | Buy | $4.00 | N/A | Reiterates | a year ago |
Abcellera Biologics IncABCL | 2 | Strong Buy | $12.00 | N/A | Maintains | 2 years ago |
Molekule Group IncMKULQ | 4 | Buy | $7.00 | N/A | Reiterates | 2 years ago |
Fortress Biotech IncFBIO | 1 | Buy | $75.00 | N/A | Reiterates | 2 years ago |
Repligen CorpRGEN | 1 | Strong Buy | $230.00 | N/A | Initiates Coverage On | 2 years ago |
Danaher CorpDHR | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Thermo Fisher Scientific IncTMO | 1 | Strong Buy | $580.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.